Evidence map›Paper›PMID 38672600›Full record

ArticleCancers2024

Ocular and Periocular Metastasis in Breast Cancer: Clinical Characteristics, Prognostic Factors and Treatment Outcome.

Yacoub A Yousef, Mona Mohammad, Hanan Khalil, Tala Khouri, Rand Alsweiti, Jakub Khzouz, Dima Abu Laban, Imad Jaradat, Ahmad Kh Ibrahimi, Akram Al-Ibraheem and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 7 citations in OpenAlex.

  1. Woman with Painless Visual Reduction.Journal of the American College of Emergency Physicians open · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Yacoub A YousefDepartment of Surgery (Ophthalmology), King Hussein Cancer Center, Amman 11941, Jordan.ORCID 0000-0001-7750-6454
Mona MohammadDepartment of Surgery (Ophthalmology), King Hussein Cancer Center, Amman 11941, Jordan.ORCID 0000-0002-8318-1171
Hanan KhalilDepartment of Medical Oncology, King Hussein Cancer Center, Amman 11941, Jordan.
Tala KhouriDepartment of Surgery (Ophthalmology), King Hussein Cancer Center, Amman 11941, Jordan.
Rand AlsweitiDepartment of Surgery (Ophthalmology), King Hussein Cancer Center, Amman 11941, Jordan.
Jakub KhzouzDepartment of Pathology, King Hussein Cancer Center, Amman 11941, Jordan.
Dima Abu LabanDepartment of Radiology, King Hussein Cancer Center, Amman 11941, Jordan.
Imad JaradatDepartment of Radiation Oncology, King Hussein Cancer Center, Amman 11941, Jordan.
Ahmad Kh IbrahimiDepartment of Radiation Oncology, King Hussein Cancer Center, Amman 11941, Jordan.ORCID 0000-0001-6256-861X
Akram Al-IbraheemDepartment of Nuclear Medicine, King Hussein Cancer Center, Amman 11941, Jordan.ORCID 0000-0002-0978-4716
Mahmoud Al MasriDepartment of Surgery, King Hussein Cancer Center, Amman 11941, Jordan.
Ibrahim AlNawiasehDepartment of Surgery (Ophthalmology), King Hussein Cancer Center, Amman 11941, Jordan.
Hikmat Abdel-RazeqDepartment of Medical Oncology, King Hussein Cancer Center, Amman 11941, Jordan.ORCID 0000-0003-2833-6051
King Hussein Cancer Center · JOUniversity of Jordan · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer remains a leading cause of cancer-related mortality and morbidity worldwide. Ocular and periocular metastasis present as a rare but clinically significant manifestation. This study aims to explore demographics and clinical aspects of ocular and periocular metastasis in breast cancer patients.

methodsA retrospective cohort study comprising 45 breast cancer patients with ocular or periocular metastasis treated between 2013 and 2023. Patient demographics, tumor characteristics, diagnostic methods, treatment modalities, visual outcomes, and survival data were analyzed.

resultsAmong 9902 breast cancer patients, 0.5% developed ocular or periocular metastasis, constituting 2.4% of metastatic cases. The median age was 50 years. Ocular metastasis timing varied: 5% before breast cancer, 24% concurrent, 22% within a year, and 49% after. The most common presentations included incidental MRI findings (42%) and vision decline (31%). Metastasis involved the orbit (47%), choroid (40%), optic nerve (11%), and iris (2%), with 44% having bilateral involvement. Predictive factors included invasive lobular carcinoma (ILC) (

conclusionsOcular metastasis in breast cancer is rare (0.5%) but signifies poor outcome. It is linked to ILC and concurrent brain metastasis. Primary treatment involves radiation therapy, with a favorable visual prognosis.

Indexed as

breast cancerchoroidal metastasisocular metastasisperiocular metastasistreatment outcomes

Identifiers

PMID38672600
PMCPMC11048436
OpenAlexW4394836877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.